# Genetic Mechanisms in Human Hypertension Renin-angiotensin-aldosterone System (RAAS) Inhibition Study

> **NCT01009944** · NA · WITHDRAWN · sponsor: **Brigham and Women's Hospital**

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Lisinopril, Atenolol

## Key facts

- **NCT ID:** NCT01009944
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-01
- **Primary completion:** 2019-03-19
- **Final completion:** 2019-03-19
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Not funded.
- **Last updated:** 2021-04-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01009944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01009944, "Genetic Mechanisms in Human Hypertension Renin-angiotensin-aldosterone System (RAAS) Inhibition Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01009944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*